Management of coronary artery disease in a severe haemophilia patient with high titre inhibitor and anaphylaxis

Haemophilia

Volumn 15, Issue 5, 2009, Pages 1161-1163

  Rivolta, G F ^a   Di Perna, C ^a   Franchini, M ^b   Ippolito, L ^a   Maurizio, A R ^a   Rocci, A ^a   Tagliaferri, Annarita ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 INHIBITOR; COMPLEMENT COMPONENT C3; EMOCLOT; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 8; UNCLASSIFIED DRUG;

AGED; ALLERGIC REACTION; ANAMNESIS; ANAPHYLAXIS; ANGIOCARDIOGRAPHY; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BLEEDING; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; CRYOPRECIPITATE; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; DUODENAL ULCER BLEEDING; HEMARTHROSIS; HEMOPHILIA A; HUMAN; IMMUNOLOGICAL TOLERANCE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PRURITUS; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS; URTICARIA;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FACTOR VIIA; FACTOR VIII; HEMOPHILIA A; HUMANS; MALE; PREOPERATIVE CARE; RECOMBINANT PROTEINS; RENAL INSUFFICIENCY, CHRONIC; TREATMENT OUTCOME;

EID: 69949094348     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2009.02050.x     Document Type: Article

References (16)

1. Mannucci PM, Tuddenham EG. The hemophilias - from royal genes to gene therapy. N Engl J Med 2001; 344: 1773-9.
2. Mejia-Carvajal C, Czapek EE, Valentino LA. Life expectancy in hemophilia outcome. J Thromb Haemost 2006; 4: 507-9.
3. Franchini M, Tagliaferri A, Mannucci PM. The management of haemophilia in elderly patients. Clin Interv Aging 2007; 2: 361-8.
4. Clapp R, Green D. Reaction to rapidly infused AHF cryoprecipitate. N Engl J Med 1969; 281: 329.
5. Helmer RE, Alperin JB, Yunginger JW, Grant JA. Anaphylactic reactions following infusion of factor VIII in a patient with classic hemophilia. Am J Med 1980; 69: 953-7.
6. Bove JR. Anaphylactic reaction to purified anti-hemophilic factor concentrate. Transfusion 1988; 26: 603.
7. Harper JL, Gill JC, Hopp RJ, Evans J, Haire WD. Induction of immune tolerance in a 7-year-old hemophiliac with an anaphylactoid inhibitor. Thromb Haemost 1995; 74: 1039-41.
8. Shopnick RI, Kazemi M, Brettler DB, et al. Anaphylaxis after treatment with recombinant factor VIII. Transfusion 1996; 36: 358-61.
9. Kadar JG, Schuster J, Hunzelmann N. IgE-mediated anaphylactic reaction to purified and recombinant factor VIII in a patient with severe haemophilia A. Haemophilia 2007; 13: 104-5.
10. Tsuchiya H, Shima M, Yoshioka A. Anaphylactic response to factor VIII preparations in a haemophilic child with an inhibitor of high titre during the tolerance induction. Eur J Pediatr 1998; 157: 85.
11. Pernod G, Armari C, Barro C et al. Anaphylaxis following the use of a plasma-derived immunopurified monoclate-P, and the recombinant Recombinate and Kogenate factor VIII: A therapeutic challenge. Haemophilia 1999; 5: 143-4.
12. Shakib F, Stanworth DR. IgG4: A possible mediator of anaphylaxis in a haemophiliac patient. Clin Allergy 1979; 9: 597-603.
13. Jadhav M, Warrier I. Anaphylaxis in patients with hemophilia. Semin Thromb Hemost 2000; 26: 205-8.
14. Krolick MA. Successful percutaneous coronary intervention in a patient with severe haemophilia A using bivalirudin as the sole procedural anticoagulant. Haemophilia 2005; 11: 415-7.
15. Smolka G, Kulach A, Dabek J, Szulc A, Gasior Z. Percutaneous coronary intervention with stent implantation in haemophilic A patient with unstable angina. Haemophilia 2007; 13: 428-31.
16. MacKinlay N, Taper J, Renisson F, Rickard K. Cardiac surgery and catheterization in patients with Haemophilia. Haemophilia 2000; 6: 84-8.